107 related articles for article (PubMed ID: 20668805)
1. [Pathologic gambling as an adverse effect of the treatment for Parkinson's disease].
Miranda M; Slachevsky A; Bustamante L; Pérez C
Rev Med Chil; 2010 Apr; 138(4):521-2. PubMed ID: 20668805
[No Abstract] [Full Text] [Related]
2. [Pathological gambling associated with pramipexole use in Parkinson's disease].
Lester J; Gonzalez-Aleman G; Zuniga-Ramirez C; Diaz-Pascuali SP; Raina-Castellino GB; Micheli-Gould F
Rev Neurol; 2006 Sep 1-15; 43(5):316-8. PubMed ID: 16941434
[No Abstract] [Full Text] [Related]
3. Is pathological gambling in Parkinson's disease reduced by amantadine?
Lee JY; Kim HJ; Jeon BS
Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095
[No Abstract] [Full Text] [Related]
4. Clozapine for medication-related pathological gambling in Parkinson disease.
Rotondo A; Bosco D; Plastino M; Consoli A; Bosco F
Mov Disord; 2010 Sep; 25(12):1994-5. PubMed ID: 20669252
[No Abstract] [Full Text] [Related]
5. Finasteride attenuates pathological gambling in patients with Parkinson disease.
Bortolato M; Cannas A; Solla P; Bini V; Puligheddu M; Marrosu F
J Clin Psychopharmacol; 2012 Jun; 32(3):424-5. PubMed ID: 22534502
[No Abstract] [Full Text] [Related]
6. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
Gerschlager W; Bloem BR
Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
[No Abstract] [Full Text] [Related]
7. Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.
Vitale C; Santangelo G; Verde F; Amboni M; Sorrentino G; Grossi D; Barone P
Mov Disord; 2010 Dec; 25(16):2893-4. PubMed ID: 20687190
[No Abstract] [Full Text] [Related]
8. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
Katz KA; Cotsarelis G; Gupta R; Seykora JT
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518
[No Abstract] [Full Text] [Related]
9. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Weintraub D; Koester J; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Arch Neurol; 2010 May; 67(5):589-95. PubMed ID: 20457959
[TBL] [Abstract][Full Text] [Related]
10. Drugs can trigger pathological gambling.
Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
[TBL] [Abstract][Full Text] [Related]
12. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
13. Pathological gambling in Parkinson's disease.
Stocchi F
Lancet Neurol; 2005 Oct; 4(10):590-2. PubMed ID: 16168925
[No Abstract] [Full Text] [Related]
14. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Montastruc JL; Schmitt L; Bagheri H
Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.
Perez Lloret S; Rascol O
Expert Opin Pharmacother; 2010 Sep; 11(13):2221-30. PubMed ID: 20670197
[TBL] [Abstract][Full Text] [Related]
16. Internet gambling and other pathological gambling in Parkinson's disease: a case series.
Wong SH; Cowen Z; Allen EA; Newman PK
Mov Disord; 2007 Mar; 22(4):591-3. PubMed ID: 17266073
[No Abstract] [Full Text] [Related]
17. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Parkinson's disease--where do we go from here?
Suchowersky O
Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605
[No Abstract] [Full Text] [Related]
19. Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.
Odiyoor M; Kobylecki C; Hackett RJ; Silverdale MA; Kellett MW
Mov Disord; 2009 Dec; 24(16):2434-5. PubMed ID: 19891000
[No Abstract] [Full Text] [Related]
20. Impact of pramipexole on the onset of levodopa-related dyskinesias.
Constantinescu R; Romer M; McDermott MP; Kamp C; Kieburtz K;
Mov Disord; 2007 Jul; 22(9):1317-9. PubMed ID: 17534955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
